Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size, Status and Forecast 2022

Publisher Name :
Date: 10-Nov-2017
No. of pages: 98
Inquire Before Buying

This report studies the global Autologous Matrix-Induced Chondrogenesis (AMIC) market, analyzes and researches the Autologous Matrix-Induced Chondrogenesis (AMIC) development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like

- Anika Therapeutics, Inc.

- Arthro-Kinetics

- B. Braun Melsungen AG

- BioTissue AG

- CartiHeal

- Geistlich Pharma AG

- JRI Orthopaedics Ltd.

- Matricel GmbH

- Smith & Nephew plc

- Zimmer Biomet Holdings

Market segment by Regions/Countries, this report covers

- United States

- EU

- Japan

- China

- India

- Southeast Asia

Market segment by Type, the product can be split into

- Hyaluronic Acid

- Collagen

- Polyethylene glycol (PEG)

- polylactic-co-glycolic acid (PGLA)

- Others

Market segment by Application, Autologous Matrix-Induced Chondrogenesis (AMIC) can be split into

- Knee Cartilage Repair

- Hip Cartilage Repair

- Elbow Cartilage Repair

- Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size, Status and Forecast 2022

Table of Contents
Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size, Status and Forecast 2022
1 Industry Overview of Autologous Matrix-Induced Chondrogenesis (AMIC)
1.1 Autologous Matrix-Induced Chondrogenesis (AMIC) Market Overview
1.1.1 Autologous Matrix-Induced Chondrogenesis (AMIC) Product Scope
1.1.2 Market Status and Outlook
1.2 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Autologous Matrix-Induced Chondrogenesis (AMIC) Market by Type
1.3.1 Hyaluronic Acid
1.3.2 Collagen
1.3.3 Polyethylene glycol (PEG)
1.3.4 polylactic-co-glycolic acid (PGLA)
1.3.5 Others
1.4 Autologous Matrix-Induced Chondrogenesis (AMIC) Market by End Users/Application
1.4.1 Knee Cartilage Repair
1.4.2 Hip Cartilage Repair
1.4.3 Elbow Cartilage Repair
1.4.4 Others
2 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Competition Analysis by Players
2.1 Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 Anika Therapeutics, Inc.
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Arthro-Kinetics
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 B. Braun Melsungen AG
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 BioTissue AG
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 CartiHeal
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Geistlich Pharma AG
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 JRI Orthopaedics Ltd.
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Matricel GmbH
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Smith & Nephew plc
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Zimmer Biomet Holdings
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (Value) (2012-2017)
3.10.5 Recent Developments
4 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Type and Application (2012-2017)
4.1 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Type (2012-2017)
4.2 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Application (2012-2017)
4.3 Potential Application of Autologous Matrix-Induced Chondrogenesis (AMIC) in Future
4.4 Top Consumer/End Users of Autologous Matrix-Induced Chondrogenesis (AMIC)
5 United States Autologous Matrix-Induced Chondrogenesis (AMIC) Development Status and Outlook
5.1 United States Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (2012-2017)
5.2 United States Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Market Share by Players (2016 and 2017)
6 EU Autologous Matrix-Induced Chondrogenesis (AMIC) Development Status and Outlook
6.1 EU Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (2012-2017)
6.2 EU Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Market Share by Players (2016 and 2017)
7 Japan Autologous Matrix-Induced Chondrogenesis (AMIC) Development Status and Outlook
7.1 Japan Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (2012-2017)
7.2 Japan Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Market Share by Players (2016 and 2017)
8 China Autologous Matrix-Induced Chondrogenesis (AMIC) Development Status and Outlook
8.1 China Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (2012-2017)
8.2 China Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Market Share by Players (2016 and 2017)
9 India Autologous Matrix-Induced Chondrogenesis (AMIC) Development Status and Outlook
9.1 India Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (2012-2017)
9.2 India Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Market Share by Players (2016 and 2017)
10 Southeast Asia Autologous Matrix-Induced Chondrogenesis (AMIC) Development Status and Outlook
10.1 Southeast Asia Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (2012-2017)
10.2 Southeast Asia Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Market Share by Players (2016 and 2017)
11 Market Forecast by Regions, Type and Application (2017-2022)
11.1 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Value) by Regions (2017-2022)
11.1.1 United States Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2017-2022)
11.1.2 EU Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2017-2022)
11.1.3 Japan Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2017-2022)
11.1.4 China Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2017-2022)
11.1.5 India Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2017-2022)
11.2 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Value) by Type (2017-2022)
11.3 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Application (2017-2022)
12 Autologous Matrix-Induced Chondrogenesis (AMIC) Market Dynamics
12.1 Autologous Matrix-Induced Chondrogenesis (AMIC) Market Opportunities
12.2 Autologous Matrix-Induced Chondrogenesis (AMIC) Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Autologous Matrix-Induced Chondrogenesis (AMIC) Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Autologous Matrix-Induced Chondrogenesis (AMIC) Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 Research Finding/Conclusion
15 Appendix
Methodology
Analyst Introduction
Data Source
List of Tables and Figures
Figure Autologous Matrix-Induced Chondrogenesis (AMIC) Product Scope
Figure Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) (2012-2017)
Table Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share by Regions in 2016
Figure United States Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share by Type in 2016
Figure Hyaluronic Acid Market Size (Million USD) and Growth Rate (2012-2017)
Figure Collagen Market Size (Million USD) and Growth Rate (2012-2017)
Figure Polyethylene glycol (PEG) Market Size (Million USD) and Growth Rate (2012-2017)
Figure polylactic-co-glycolic acid (PGLA) Market Size (Million USD) and Growth Rate (2012-2017)
Figure Others Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share by Application in 2016
Table Key Downstream Customer in Knee Cartilage Repair
Figure Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) and Growth Rate in Knee Cartilage Repair (2012-2017)
Table Key Downstream Customer in Hip Cartilage Repair
Figure Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) and Growth Rate in Hip Cartilage Repair (2012-2017)
Table Key Downstream Customer in Elbow Cartilage Repair
Figure Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) and Growth Rate in Elbow Cartilage Repair (2012-2017)
Table Key Downstream Customer in Others
Figure Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) and Growth Rate in Others (2012-2017)
Table Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) by Players (2016 and 2017)
Figure Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Share by Players in 2016
Figure Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Share by Players in 2017
Table Anika Therapeutics, Inc. Basic Information List
Table Autologous Matrix-Induced Chondrogenesis (AMIC) Business Revenue (Million USD) of Anika Therapeutics, Inc. (2012-2017)
Figure Anika Therapeutics, Inc. Autologous Matrix-Induced Chondrogenesis (AMIC) Business Revenue Market Share in 2016
Table Arthro-Kinetics Basic Information List
Table Autologous Matrix-Induced Chondrogenesis (AMIC) Business Revenue (Million USD) of Arthro-Kinetics (2012-2017)
Figure Arthro-Kinetics Autologous Matrix-Induced Chondrogenesis (AMIC) Business Revenue Market Share in 2016
Table B. Braun Melsungen AG Basic Information List
Table Autologous Matrix-Induced Chondrogenesis (AMIC) Business Revenue (Million USD) of B. Braun Melsungen AG (2012-2017)
Figure B. Braun Melsungen AG Autologous Matrix-Induced Chondrogenesis (AMIC) Business Revenue Market Share in 2016
Table BioTissue AG Basic Information List
Table Autologous Matrix-Induced Chondrogenesis (AMIC) Business Revenue (Million USD) of BioTissue AG (2012-2017)
Figure BioTissue AG Autologous Matrix-Induced Chondrogenesis (AMIC) Business Revenue Market Share in 2016
Table CartiHeal Basic Information List
Table Autologous Matrix-Induced Chondrogenesis (AMIC) Business Revenue (Million USD) of CartiHeal (2012-2017)
Figure CartiHeal Autologous Matrix-Induced Chondrogenesis (AMIC) Business Revenue Market Share in 2016
Table Geistlich Pharma AG Basic Information List
Table Autologous Matrix-Induced Chondrogenesis (AMIC) Business Revenue (Million USD) of Geistlich Pharma AG (2012-2017)
Figure Geistlich Pharma AG Autologous Matrix-Induced Chondrogenesis (AMIC) Business Revenue Market Share in 2016
Table JRI Orthopaedics Ltd. Basic Information List
Table Autologous Matrix-Induced Chondrogenesis (AMIC) Business Revenue (Million USD) of JRI Orthopaedics Ltd. (2012-2017)
Figure JRI Orthopaedics Ltd. Autologous Matrix-Induced Chondrogenesis (AMIC) Business Revenue Market Share in 2016
Table Matricel GmbH Basic Information List
Table Autologous Matrix-Induced Chondrogenesis (AMIC) Business Revenue (Million USD) of Matricel GmbH (2012-2017)
Figure Matricel GmbH Autologous Matrix-Induced Chondrogenesis (AMIC) Business Revenue Market Share in 2016
Table Smith & Nephew plc Basic Information List
Table Autologous Matrix-Induced Chondrogenesis (AMIC) Business Revenue (Million USD) of Smith & Nephew plc (2012-2017)
Figure Smith & Nephew plc Autologous Matrix-Induced Chondrogenesis (AMIC) Business Revenue Market Share in 2016
Table Zimmer Biomet Holdings Basic Information List
Table Autologous Matrix-Induced Chondrogenesis (AMIC) Business Revenue (Million USD) of Zimmer Biomet Holdings (2012-2017)
Figure Zimmer Biomet Holdings Autologous Matrix-Induced Chondrogenesis (AMIC) Business Revenue Market Share in 2016
Table Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) by Type (2012-2017)
Figure Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Share by Type in 2012
Figure Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Share by Type in 2013
Figure Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Share by Type in 2014
Figure Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Share by Type in 2015
Figure Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Share by Type in 2016
Figure Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Share by Type in 2017
Table Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) by Application (2012-2017)
Figure Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) by Application in 2012
Figure Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) by Application in 2013
Figure Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) by Application in 2014
Figure Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) by Application in 2015
Figure Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) by Application in 2016
Figure Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Autologous Matrix-Induced Chondrogenesis (AMIC)
Figure United States Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) by Players (2012-2017)
Figure United States Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Share by Players in 2016
Figure United States Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Share by Players in 2017
Figure EU Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) by Players (2012-2017)
Figure EU Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Share by Players in 2016
Figure EU Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Share by Players in 2017
Figure Japan Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) by Players (2012-2017)
Figure Japan Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Share by Players in 2016
Figure Japan Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Share by Players in 2017
Figure China Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) by Players (2012-2017)
Figure China Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Share by Players in 2016
Figure China Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Share by Players in 2017
Figure India Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) by Players (2012-2017)
Figure India Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Share by Players in 2016
Figure India Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Share by Players in 2017
Figure Southeast Asia Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Share by Players in 2016
Figure Southeast Asia Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Share by Players in 2017
Figure Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) by Regions (2017-2022)
Table Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) by Regions (2017-2022)
Figure Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Share by Regions in 2017
Figure Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Share by Regions in 2022
Figure United States Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) by Type (2017-2022)
Figure Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Share by Type in 2017
Figure Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Share by Type in 2022
Table Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) by Application (2017-2022)
Figure Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) by Application in 2017
Figure Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) by Application in 2022
  • 2018 Top 5 Erythropoietin Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa
    Published: 15-Jun-2018        Price: US 4960 Onwards        Pages: 125
    Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood. Erythropoietin is an essential hormone for red blood cell production. Without it, definitive erythropoiesis does not take place. Under hypoxic conditions, t......
  • 2018-2023 Global Erythropoietin Consumption Market Report
    Published: 15-Jun-2018        Price: US 4660 Onwards        Pages: 131
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Erythropoietin market for 2018-2023. Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adult......
  • 2018 Top 5 PEGylated Proteins Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa
    Published: 15-Jun-2018        Price: US 4960 Onwards        Pages: 125
    PEGylating has been widely used as a post-production modification methodology for improving biomedical efficacy and physicochemical properties of therapeutic proteins since the first PEGylated product was approved by Food and Drug Administration in the early 1990s. The threat of substitutes arises when there are similar products developed by competitors which satisfy the market needs. When consumers have access to substitute products which can satisfy their market needs, then manufacturer......
  • 2018-2023 Global PEGylated Proteins Consumption Market Report
    Published: 15-Jun-2018        Price: US 4660 Onwards        Pages: 138
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global PEGylated Proteins market for 2018-2023. PEGylating has been widely used as a post-production modification methodology for improving biomedical efficacy and physicochemical properties of therapeutic proteins since the first PEGylated product was approved by Food and Drug Administration in the early 1990s. The threat of substitutes arises when there a......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Enzymatic Debridement Market 2018, Forecast to 2023
    Published: 15-Jun-2018        Price: US 4880 Onwards        Pages: 133
    Enzymatic Debridement uses chemical enzymes to assist in wound healing. Enzymes that help slough off the dead tissue are often available as part of a topic ointment; however, the ointment must be carefully applied to only the currently dead tissue - if the enzymes come in contact with healthy tissue, they could cause issues. Scope of the Report: This report focuses on the Enzymatic Debridement in global market, especially in North America, Europe and Asia-Pacific, South Ame......
  • Global Enzymatic Debridement Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 15-Jun-2018        Price: US 3480 Onwards        Pages: 129
    Enzymatic Debridement uses chemical enzymes to assist in wound healing. Enzymes that help slough off the dead tissue are often available as part of a topic ointment; however, the ointment must be carefully applied to only the currently dead tissue - if the enzymes come in contact with healthy tissue, they could cause issues. Scope of the Report: This report focuses on the Enzymatic Debridement in global market, especially in North America, Europe and Asia-Pacific, South Ame......
  • Global Vaccine Market, People Vaccinated, Administered, Immunization, By Disease, By End User, Companies
    Published: 14-Jun-2018        Price: US 1990 Onwards        Pages: 355
    Global Vaccine Market is projected to reach US$ 70 Billion by the year 2024. The vaccine market is likely to witness a significant growth throughout the forecast period due to the growing prevalence of diseases, increasing government and non-government funding for vaccine development & distribution and increasing investments by companies to develop new vaccines. Furthermore, growing demand for preventive vaccines, rising consciousness about vaccination coupled with mounting demand from th......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Celery Seed Extract Solid Market 2018, Forecast to 2023
    Published: 13-Jun-2018        Price: US 4880 Onwards        Pages: 128
    Celery seed solid extract and oil are majorly used for healthcare benefits as anti-spasmodic, nerve stimulant, stimulant and tonic in asthma, rheumatoid arthritis, intestinal antiseptic. The essential oil of celery seed comprise of sesquiterpene alcohols, sedanolide, d-limonene, selinene, and sedanonic anhydride. Celery oil is mostly used for flavoring of food and perfumes. Scope of the Report: This report focuses on the Celery Seed Extract Solid in global market, especial......
  • Global Celery Seed Extract Solid Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 13-Jun-2018        Price: US 3480 Onwards        Pages: 135
    Celery seed solid extract and oil are majorly used for healthcare benefits as anti-spasmodic, nerve stimulant, stimulant and tonic in asthma, rheumatoid arthritis, intestinal antiseptic. The essential oil of celery seed comprise of sesquiterpene alcohols, sedanolide, d-limonene, selinene, and sedanonic anhydride. Celery oil is mostly used for flavoring of food and perfumes. Scope of the Report: This report focuses on the Celery Seed Extract Solid in global market, especial......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs